例如:"NBL1", "4681", "drought"
收藏
959 CD40LG

959

CD40LG

CD40 ligand

protein-coding

Homo sapiens

基因描述

Type Description
Definition CD40 ligand

研究结论

Date Results Publications
2021-02-02 13:22:00 CD154-expressing CMV-specific T cells associate with freedom from DNAemia and may be protective in seronegative recipients after liver or intestine transplantation. 31657119
2020-12-05 13:04:00 Decreased mRNA Expressions of CD40L in Patients with Neuromyelitis Optica Spectrum Disorder. 31925706
2020-11-21 13:31:00 Inverse relationship between CD40L expression and cytolytic molecule expression by CD8(+)CXCR5(+) T follicular cytotoxic cells in colorectal cancer. 32035135
2020-10-03 12:59:00 CD154 inhibits death of T cells via a Cis interaction with the alpha5beta1 integrin. 32745080
2020-08-12 10:58:00 Soluble sCD40L is not associated with cardiovascular or all-cause mortality. 31558283

名称对应

Type IDs
Synonymous CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L
Gene
UniProtKB-ID: CD40L_HUMAN
UniprotKB: P29965
UniParc: UPI00000315E7
EMBL: BC071754, X67878, D31797, L07414, Z15017, BC074950, X68550
Ensembl: ENSG00000102245
KO: hsa:959
Nucleutide sequences
EMBL-CDS: AAH74950.1, AAA35662.1, BAA06599.1, CAA78737.1, CAA48077.1, AAH71754.1, CAA48554.1
Ensembl_TRS: ENST00000370629
Protein sequencees
Ensembl_PRO: ENSP00000359663
RefSeq: NP_000065.1
Others
UniRef100: UniRef100_P29965
UniRef90: UniRef90_P29965
UniRef50: UniRef50_P29965
UniGene: Hs.592244
CCDS: CCDS14659.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员